MAG
ABBV icon

MRA Advisory Group’s AbbVie ABBV Stock Holding History

MRA Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Buy
7,883
+5,215
+195% +$1.12M 0.72% 30
2026
Q1 		$580K Sell
2,668
-20
-0.7% -$4.44K 0.24% 62
2025
Q4 		$614K Sell
2,688
-201
-7% -$45.8K 0.26% 58
2025
Q3 		$669K Sell
2,889
-1
-0% -$204 0.29% 49
2025
Q2 		$536K Sell
2,890
-549
-16% -$102K 0.25% 63
2025
Q1 		$721K Buy
3,439
+292
+9% +$56.8K 0.38% 34
2024
Q4 		$559K Buy
3,147
+155
+5% +$28.5K 0.3% 42
2024
Q3 		$591K Buy
2,992
+16
+0.5% +$2.99K 0.32% 40
2024
Q2 		$510K Buy
2,976
+383
+15% +$63.4K 0.29% 45
2024
Q1 		$472K Buy
2,593
+654
+34% +$113K 0.28% 50
2023
Q4 		$300K Sell
1,939
-741
-28% -$108K 0.2% 65
2023
Q3 		$400K Sell
2,680
-559
-17% -$82.1K 0.29% 68
2023
Q2 		$436K Buy
3,239
+226
+8% +$33.1K 0.3% 56
2023
Q1 		$480K Buy
3,013
+615
+26% +$94K 0.35% 53
2022
Q4 		$388K Sell
2,398
-205
-8% -$31.4K 0.3% 67
2022
Q3 		$360K Sell
2,603
-143
-5% -$20.5K 0.31% 69
2022
Q2 		$421K Buy
2,746
+140
+5% +$21.4K 0.37% 62
2022
Q1 		$422K Buy
2,606
+23
+0.9% +$3.34K 0.32% 64
2021
Q4 		$350K Sell
2,583
-3,692
-59% -$436K 0.27% 71
2021
Q3 		$677K Buy
6,275
+383
+7% +$43.8K 0.58% 41
2021
Q2 		$664K Sell
5,892
-334
-5% -$37.6K 0.57% 40
2021
Q1 		$674K Buy
6,226
+175
+3% +$18.7K 0.63% 38
2020
Q4 		$648K Buy
+6,051
New +$581K 0.64% 38

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

MRA Advisory Group's ABBV Position: Q2 2026 in Review

MRA Advisory Group increased its AbbVie (ABBV) stake by 195% in Q2 2026, buying an estimated $1.12M and bringing the position to 7,883 shares worth $1.98M. The position accounts for 0.72% of the portfolio, ranked #30.

MRA Advisory Group first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 1,482 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MRA Advisory Group held 7,883 shares of AbbVie worth $1.98M as of Q2 2026.
  • MRA Advisory Group bought 5,215 AbbVie shares in Q2 2026, an estimated $1.12M.
  • AbbVie made up 0.72% of MRA Advisory Group's portfolio in Q2 2026, its #30 holding.
  • MRA Advisory Group first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 1,482 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MRA Advisory Group's 13F filing for Q2 2026, filed 8 Jul 2026.